Akèy › Dyabèt Tip 2 › Pennsylvania
Etid klinik pou Dyabèt Tip 2 nan Pennsylvania
30 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Heritage Valley Medical Group, Beaver
- Capital Area Research, LLC, Camp Hill
- Thomas Jefferson University, Philadelphia
- ak 8 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Heritage Valley Medical Group, Beaver
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07564414A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Heritage Valley Medical Group, Beaver
- Preferred Primary Care Physicians-Pittsburgh-63932, Pittsburgh
- Preferred Primary Care Physicians, Pittsburgh
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Capital Area Research, Camp Hill
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Smithfield
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair, Pittsburgh
- Preferred Primary Care Physicians, Uniontown
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Scottdale
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270Phenotyping Genetic Risk for Type 2 Diabetes
- Childrens Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
Ap rekriteVolontè an sante akeyi
Laj 10 a 70 · Tout sèks · Mizajou Sep 21, 2026 · NCT04024631A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Philadelphia
- AURORA-2 Clinical Site, Pittsburgh
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- VA Pittsburgh Healthcare System, Pittsburgh
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Frontier Clinical Research, LLC, Scottdale
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT06897475Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Northeast Clinical Research Center, Bethlehem
- Suburban Research Associates, West Chester
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Preferred Primary Care Physicians, Inc., Uniontown
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07668388A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Children's Hosptl Philadelphia, Philadelphia
Ap rekriteFaz 3
Laj 10 a 18 · Tout sèks · Mizajou Sep 9, 2026 · NCT07282613A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Feasterville-Trevose
- Research Site, Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Suburban Research Associates, West Chester
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Heritage Valley Medical Group, Beaver
- Capital Area Research LLC, Newport
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Children's Hospital of Philadelphia, Philadelphia
- St Christophers Hospital For Children, Philadelphia
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122The GRoceries Aimed at Increasing Nutrition Study
- University of Pennsylvania, Philadelphia
Ap rekriteMande peman pou patisipan yo
Laj 45 a 70 · Tout sèks · Mizajou Aug 6, 2026 · NCT07167004Pharmacogenetics of Response to GLP1R Agonists
- Amish Research Clinic, Lancaster
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 89 · Tout sèks · Mizajou Jul 27, 2026 · NCT05071898Sleep and Glycemic Control in Type 2 Diabetes Adolescents
- Children's Hospital of Philadelphia, Philadelphia
Ap rekrite
Laj 12 a 20 · Tout sèks · Mizajou Jun 29, 2026 · NCT04213547CGM for Management of Type 2 Diabetes in Pregnancy
- University of Pennsylvania, Philadelphia
Ap rekrite
Laj 18 a 50 · Fanm · Mizajou Jun 29, 2026 · NCT06628453DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Children's Hospital of Philadelphia, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 8 a 15 · Tout sèks · Mizajou May 7, 2026 · NCT06525259Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Ap rekriteVolontè an sante akeyi
Laj 13 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT07216118Transformative Research in Diabetic Nephropathy 2.0
- Penn Presbyterian Medical Center, Philadelphia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 2, 2026 · NCT07444203Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes
- Children's Hospital of Pittsburgh, Pittsburgh
Ap rekrite
Laj 16 a 24 · Tout sèks · Mizajou Feb 20, 2026 · NCT07270016Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 12 a 17 · Tout sèks · Mizajou Dec 18, 2025 · NCT05277558CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
- Thomas Jefferson University, Philadelphia
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Oct 14, 2025 · NCT07184775Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
- Reading Hospital, an affiliate of Tower Health, West Reading
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2025 · NCT05893927Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.